Terms: = Thyroid cancer AND GNAS, RP4-543J19_4, 2778, ENSG00000087460, NESP55, NESP, GSP, POH, GNASXL, GNAS1, C20orf45, dJ309F20_1_1, SCG6, GPSA, Gnas, dJ806M20_3_3, XL2, MGC33735, XL, PHP1A, GSA, AHO, XLalphas, PHP1B
18831 results:
1. Feasibility and safety of modified en-bloc resection in endoscopic thyroid surgery via bilateral areolar approach - long-term institutional analysis ten years after surgery.
Xie Q; Ma J; Du Y; Liu L; Zhu R; Liu D; Wang P; Yu X
Front Endocrinol (Lausanne); 2024; 15():1302510. PubMed ID: 38694946
[TBL] [Abstract] [Full Text] [Related]
2. Accuracy and diagnostic performance of the Bethesda system for reporting thyroid cytopathology in a tertiary endocrine surgical referral center in Belgium.
Kinet S; Cornette H; Van Den Heede K; Brusselaers N; Van Slycke S
World J Surg; 2024 Feb; 48(2):386-392. PubMed ID: 38686788
[TBL] [Abstract] [Full Text] [Related]
3. The clinical value of iodine-125 seed implantation in the treatment of iodine-refractory differentiated thyroid carcinoma.
Wan Q; Tan L; Tang X; Wang W; Su Y; Wu Z; Ke M; Chen Z
Front Endocrinol (Lausanne); 2024; 15():1327766. PubMed ID: 38686207
[TBL] [Abstract] [Full Text] [Related]
4. Deubiquitination of CDC6 by OTUD6A promotes tumour progression and chemoresistance.
Cui J; Liu X; Shang Q; Sun S; Chen S; Dong J; Zhu Y; Liu L; Xia Y; Wang Y; Xiang L; Fan B; Zhan J; Zhou Y; Chen P; Zhao R; Liu X; Xing N; Wu D; Shi B; Zou Y
Mol Cancer; 2024 Apr; 23(1):86. PubMed ID: 38685067
[TBL] [Abstract] [Full Text] [Related]
5. Absolute lymphocyte count and neutrophil-to-lymphocyte ratio as predictors of CDK 4/6 inhibitor efficacy in advanced breast cancer.
Nakamoto S; Shien T; Iwamoto T; Kubo S; Yamamoto M; Yamashita T; Kuwahara C; Ikeda M
Sci Rep; 2024 Apr; 14(1):9869. PubMed ID: 38684839
[TBL] [Abstract] [Full Text] [Related]
6. Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study.
Pasternak B; Wintzell V; Hviid A; Eliasson B; Gudbjörnsdottir S; Jonasson C; Hveem K; Svanström H; Melbye M; Ueda P
BMJ; 2024 Apr; 385():e078225. PubMed ID: 38683947
[TBL] [Abstract] [Full Text] [Related]
7. Assessment of thyroid Carcinogenic Risk and Safety Profile of GLP1-RA Semaglutide (Ozempic) Therapy for Diabetes Mellitus and Obesity: A Systematic Literature Review.
Feier CVI; Vonica RC; Faur AM; Streinu DR; Muntean C
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673931
[TBL] [Abstract] [Full Text] [Related]
8. Chloride/Multiple Anion Exchanger SLC26A Family: Systemic Roles of SLC26A4 in Various Organs.
Lee D; Hong JH
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673775
[TBL] [Abstract] [Full Text] [Related]
9. Efficacy and safety of fibrin sealant application in patients undergoing thyroidectomy: a systematic review and meta-analysis.
Zheng X; Wang F; Su YC; Xu CY; Wang MZ
BMC Surg; 2024 Apr; 24(1):122. PubMed ID: 38658932
[TBL] [Abstract] [Full Text] [Related]
10. PD-1 inhibition with retifanlimab and/or arginase inhibition with INCB001158 in Japanese patients with solid tumors: A phase I study.
Kuboki Y; Koyama T; Matsubara N; Naito Y; Kondo S; Harano K; Yonemori K; Yoh K; Gu Y; Mita T; Chen X; Ueda E; Yamamoto N; Doi T; Shimizu T
Cancer Med; 2024 Apr; 13(8):e6980. PubMed ID: 38651187
[TBL] [Abstract] [Full Text] [Related]
11. Identification of 10 differentially expressed and cuproptosis-related genes in immune infiltration and prognosis of thyroid carcinoma.
Yu W; Liu H; Zhang Y; Liu M; Li W; Wang L; Li D
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):89-94. PubMed ID: 38650151
[TBL] [Abstract] [Full Text] [Related]
12. Prevalence and impact of endocrine disorders in advanced metastatic cancer patients undergoing cancer-directed therapy: A prospective observational study.
Karna G; Sehrawat A; Karna S; Kant R; Sundriyal D; Karn S; Jha D
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2011. PubMed ID: 38644759
[TBL] [Abstract] [Full Text] [Related]
13. Comparison of lifetime mortality risk, incidence risk, and DALYs of baseline cancer rates among countries as a benchmark for radiation-related cancer risk.
Hirouchi J; Kujiraoka I; Takahara S; Takada M; Schneider T; Kai M
J Radiol Prot; 2024 Apr; 44(2):. PubMed ID: 38636499
[TBL] [Abstract] [Full Text] [Related]
14. Applying machine-learning models to differentiate benign and malignant thyroid nodules classified as C-TIRADS 4 based on 2D-ultrasound combined with five contrast-enhanced ultrasound key frames.
Chen JH; Zhang YQ; Zhu TT; Zhang Q; Zhao AX; Huang Y
Front Endocrinol (Lausanne); 2024; 15():1299686. PubMed ID: 38633756
[TBL] [Abstract] [Full Text] [Related]
15. Using haematological indices to predict impaired liver function in DTC patients.
Zhou Y; Chai H
Hell J Nucl Med; 2024; 27(1):2-7. PubMed ID: 38629813
[TBL] [Abstract] [Full Text] [Related]
16. thyroid nodule rupture after radiofrequency ablation: case report and literature review.
Ferraro T; Sajid S; Hodak SP; Baldwin CK
Front Endocrinol (Lausanne); 2024; 15():1355383. PubMed ID: 38628591
[TBL] [Abstract] [Full Text] [Related]
17. Correlation between socioeconomic indices and epidemiological indices of thyroid cancer from 1990 to 2019 year: a global ecologic study.
Maleki Z; Hassanzadeh J; Ghaem H
BMC Cancer; 2024 Apr; 24(1):467. PubMed ID: 38622568
[TBL] [Abstract] [Full Text] [Related]
18. Multiple and hereditary renal tumors: a review for radiologists.
Corral de la Calle MÁ; Encinas de la Iglesia J; Fernández Pérez GC; Fraino A; Repollés Cobaleda M
Radiologia (Engl Ed); 2024; 66(2):132-154. PubMed ID: 38614530
[TBL] [Abstract] [Full Text] [Related]
19. Association between Consumption of Iodine-Rich Foods and thyroid cancer Prevalence: Findings from a Large Population-Based Study.
Kwon YJ; Lee HS; Kang SW; Lee JW
Nutrients; 2024 Apr; 16(7):. PubMed ID: 38613074
[TBL] [Abstract] [Full Text] [Related]
20. Diagnostic value of contrast-enhanced ultrasound in the diagnosis of papillary thyroid microcarcinoma: A systematic review and meta-analysis.
Ding Y; Peng Y; Zhang J; Pan X; Huang X; Zhang CQ
Medicine (Baltimore); 2024 Apr; 103(15):e37768. PubMed ID: 38608080
[TBL] [Abstract] [Full Text] [Related]
[Next]
